ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1,7,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1,8,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
1,9,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
2,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
7,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,2,Headache,Headaches NEC,Headaches,Nerv,N
8,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
8,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
10,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,2,Headache,Headaches NEC,Headaches,Nerv,N
11,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
13,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
13,2,Headache,Headaches NEC,Headaches,Nerv,N
13,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
13,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
14,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
15,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
17,1,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
17,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
18,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
19,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
19,2,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
20,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
21,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
22,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
23,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
23,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
23,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
23,4,Headache,Headaches NEC,Headaches,Nerv,N
23,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
23,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
23,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
23,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,10,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
23,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
24,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
25,1,Haematocrit increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
27,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
27,2,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
27,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
27,4,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
27,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
27,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
28,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
28,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
31,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
32,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
33,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
34,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
35,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
36,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
36,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
36,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
36,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,5,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,7,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
36,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
38,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
38,3,Headache,Headaches NEC,Headaches,Nerv,N
38,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
39,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
40,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
41,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
41,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
42,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
43,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
44,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
44,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
45,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
46,2,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
47,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
47,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
49,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
49,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
51,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,3,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
51,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
51,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
53,2,Migraine,Migraine headaches,Headaches,Nerv,N
54,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
54,2,Systemic-pulmonary artery shunt,Congenital cardiovascular anomaly therapeutic procedures,Cardiac therapeutic procedures,Surg,N
55,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
56,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
58,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
58,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
58,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,4,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
58,5,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
59,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
60,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
61,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
61,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
61,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
62,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
62,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
62,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
62,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
63,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
63,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
64,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
66,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
68,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
69,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
69,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
69,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
69,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
70,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
70,3,Hepatic arteriovenous malformation,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
70,4,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
70,5,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
71,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
71,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
71,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
72,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
73,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
74,1,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
75,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
76,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
77,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
78,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
80,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
80,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
81,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
82,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
84,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,3,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
84,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
85,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
88,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
89,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
91,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
94,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
98,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
99,1,Oxygen therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
100,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
101,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
102,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
103,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
103,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
105,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
107,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
108,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
109,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,1,Sight disability,Disability issues,Lifestyle issues,SocCi,N
111,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
114,1,Headache,Headaches NEC,Headaches,Nerv,N
